Evidence map›Paper›PMID 38376465›Full record

ArticleThe Journal of cell biology2024

Tunable DNMT1 degradation reveals DNMT1/DNMT3B synergy in DNA methylation and genome organization.

Andrea Scelfo, Viviana Barra, Nezar Abdennur, George Spracklin, Florence Busato, Catalina Salinas-Luypaert, Elena Bonaiti, Guillaume Velasco, Frédéric Bonhomme, Anna Chipont and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Chromatin Perturbation Promotes Susceptibility to Hypomethylating Agents.bioRxiv : the preprint server for biology · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 4 countries.

Andrea ScelfoInstitut Curie, PSL Research University, Sorbonne Université, CNRS, UMR 144 , Paris, France.ORCID 0000-0001-8767-0688
Viviana Barra *Institut Curie, PSL Research University, Sorbonne Université, CNRS, UMR 144 , Paris, France.ORCID 0000-0002-7186-4485
Nezar Abdennur *Program in Bioinformatics and Integrative Biology, UMass Chan Medical School , Worcester, MA, USA.ORCID 0000-0001-5814-0864
George Spracklin *Department of Systems Biology, UMass Chan Medical School, Worcester, MA, USA.ORCID 0000-0001-7352-7354
Florence BusatoCentre National de Recherche en Génomique Humaine, CEA-Institut de Biologie François Jacob, Université Paris-Saclay , Evry, France.ORCID 0000-0002-1459-7712
Catalina Salinas-LuypaertInstitut Curie, PSL Research University, Sorbonne Université, CNRS, UMR 144 , Paris, France.ORCID 0000-0003-1194-4536
Elena BonaitiInstitut Curie, PSL Research University, Sorbonne Université, CNRS, UMR 144 , Paris, France.ORCID 0009-0004-4199-3616
Guillaume VelascoUniversité de Paris Cité, CNRS UMR 7216 , Paris, France.ORCID 0000-0002-3620-8810
Frédéric BonhommeEpigenetic Chemical Biology, Institut Pasteur, CNRS UMR n°3523 Chem4Life, Université Paris Cité , Paris, France.ORCID 0000-0001-6797-289X
Anna ChipontCytometry Platform, Institut Curie , Paris, France.ORCID 0000-0002-3711-404X
Andréa E TijhuisEuropean Research Institute for the Biology of Ageing, University Groningen, University Medical Center Groningen , Groningen, Netherlands.ORCID 0000-0001-8150-3061
Diana C J SpieringsEuropean Research Institute for the Biology of Ageing, University Groningen, University Medical Center Groningen , Groningen, Netherlands.ORCID 0000-0001-8403-474X
Coralie GuérinCytometry Platform, Institut Curie , Paris, France.ORCID 0000-0002-1840-4017
Paola ArimondoEpigenetic Chemical Biology, Institut Pasteur, CNRS UMR n°3523 Chem4Life, Université Paris Cité , Paris, France.ORCID 0000-0001-5175-4396
Claire FrancastelUniversité de Paris Cité, CNRS UMR 7216 , Paris, France.ORCID 0000-0002-6353-4320
Floris FoijerEuropean Research Institute for the Biology of Ageing, University Groningen, University Medical Center Groningen , Groningen, Netherlands.ORCID 0000-0003-0989-3127
Jӧrg TostCentre National de Recherche en Génomique Humaine, CEA-Institut de Biologie François Jacob, Université Paris-Saclay , Evry, France.ORCID 0000-0002-2683-0817
Leonid MirnyInstitute for Medical Engineering and Sciences, Massachusetts Institute of Technology , Cambridge, MA, USA.ORCID 0000-0002-0785-5410
Daniele FachinettiInstitut Curie, PSL Research University, Sorbonne Université, CNRS, UMR 144 , Paris, France.ORCID 0000-0002-8795-6771
Centre National de la Recherche Scientifique · FRUniversity Medical Center Groningen · NLCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRInserm · FRInstitut Curie · FRMassachusetts Institute of Technology · USUMass Memorial Health Care · USUniversity of Massachusetts Chan Medical School · US

Funding

AIRCCentre National de la Recherche ScientifiqueFondation ARC pour la recherche sur le cancerInstitut CurieMarie Skłodowska-Curie Actions 800924
6 · The paper itself

Abstract

DNA methylation (DNAme) is a key epigenetic mark that regulates critical biological processes maintaining overall genome stability. Given its pleiotropic function, studies of DNAme dynamics are crucial, but currently available tools to interfere with DNAme have limitations and major cytotoxic side effects. Here, we present cell models that allow inducible and reversible DNAme modulation through DNMT1 depletion. By dynamically assessing whole genome and locus-specific effects of induced passive demethylation through cell divisions, we reveal a cooperative activity between DNMT1 and DNMT3B, but not of DNMT3A, to maintain and control DNAme. We show that gradual loss of DNAme is accompanied by progressive and reversible changes in heterochromatin, compartmentalization, and peripheral localization. DNA methylation loss coincides with a gradual reduction of cell fitness due to G1 arrest, with minor levels of mitotic failure. Altogether, this system allows DNMTs and DNA methylation studies with fine temporal resolution, which may help to reveal the etiologic link between DNAme dysfunction and human disease.

Indexed as

DNA (Cytosine-5-)-Methyltransferase 1DNA MethylationDNA Methyltransferase 3AEpigenomicsCell DivisionCell LineHeterochromatinHumansDNA (Cytosine-5-)-Methyltransferase 1DNA Methyltransferase 3ADNMT1 protein, humanDNMT3A protein, humanHeterochromatin

Identifiers

PMID38376465
PMCPMC10876481
OpenAlexW4391955145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.